Beijing Tiantan Biological Products Corp Ltd (600161) — Cash Flow Quality Index
Beijing Tiantan Biological Products Corp Ltd (600161) has a Cash Flow Quality Index of 1.71x as of September 2025. Operating cash flow of CN¥318.80 Million exceeds net income of CN¥186.12 Million, indicating high earnings quality where cash backs reported profits. Explore Beijing Tiantan Biological Products Corp strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Beijing Tiantan Biological Products Corp Ltd Cash Flow Quality Index (1998–2024)
Historical Cash Flow Quality Index for Beijing Tiantan Biological Products Corp Ltd across 27 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Beijing Tiantan Biological Products Corp (600161) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Beijing Tiantan Biological Products Corp Ltd (1998–2024)
Year-by-year earnings quality comparison for Beijing Tiantan Biological Products Corp Ltd. For live market cap and the full company financial profile, see Beijing Tiantan Biological Products Corp market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.39x | CN¥819.78 Million | CN¥2.11 Billion | ▼ -75.5% |
| 2023 | 1.59x | CN¥2.39 Billion | CN¥1.51 Billion | ▲ +69.7% |
| 2022 | 0.93x | CN¥1.13 Billion | CN¥1.20 Billion | ▲ +1.9% |
| 2021 | 0.92x | CN¥980.35 Million | CN¥1.07 Billion | ▲ +23.2% |
| 2020 | 0.74x | CN¥702.11 Million | CN¥943.08 Million | ▲ +3.6% |
| 2019 | 0.72x | CN¥642.47 Million | CN¥894.25 Million | ▼ -22.0% |
| 2018 | 0.92x | CN¥677.92 Million | CN¥735.90 Million | ▲ +425.6% |
| 2017 | 0.18x | CN¥218.39 Million | CN¥1.25 Billion | ▼ -87.6% |
| 2016 | 1.41x | CN¥428.37 Million | CN¥303.01 Million | ▼ -65.5% |
| 2015 | 4.09x | CN¥473.26 Million | CN¥115.58 Million | ▲ +93.7% |
| 2014 | 2.11x | CN¥477.95 Million | CN¥226.16 Million | ▲ +72.2% |
| 2013 | 1.23x | CN¥566.43 Million | CN¥461.48 Million | ▲ +5.1% |
| 2012 | 1.17x | CN¥432.00 Million | CN¥369.96 Million | ▼ -3.5% |
| 2011 | 1.21x | CN¥353.15 Million | CN¥291.84 Million | ▲ +46.2% |
| 2010 | 0.83x | CN¥184.85 Million | CN¥223.35 Million | ▼ -48.3% |
| 2009 | 1.60x | CN¥448.23 Million | CN¥280.18 Million | ▲ +13.0% |
| 2008 | 1.42x | CN¥276.39 Million | CN¥195.28 Million | ▲ +37.6% |
| 2007 | 1.03x | CN¥153.55 Million | CN¥149.32 Million | ▼ -30.2% |
| 2006 | 1.47x | CN¥154.36 Million | CN¥104.83 Million | ▼ -22.8% |
| 2005 | 1.91x | CN¥131.69 Million | CN¥69.00 Million | ▼ -17.6% |
| 2004 | 2.32x | CN¥110.11 Million | CN¥47.53 Million | ▲ +59.1% |
| 2003 | 1.46x | CN¥62.93 Million | CN¥43.23 Million | ▼ -37.4% |
| 2002 | 2.32x | CN¥84.38 Million | CN¥36.30 Million | ▲ +71.7% |
| 2001 | 1.35x | CN¥46.49 Million | CN¥34.35 Million | ▲ +7.3% |
| 2000 | 1.26x | CN¥47.90 Million | CN¥37.97 Million | ▲ +28.0% |
| 1999 | 0.99x | CN¥42.58 Million | CN¥43.20 Million | ▲ +39.6% |
| 1998 | 0.71x | CN¥23.71 Million | CN¥33.58 Million | — |